论文部分内容阅读
应用沈阳安迪生物高科技公司生产的人用精制Ｖｅｒｏ细胞狂犬病疫苗（ＣＩＮ－１株）进行了Ⅱ期人体临床观察。观察方案由中国预防医学科学院流行病学微生物学研究所制定，人体接种后血清抗体检测由中国药品生物制品检定所负责。观察疫苗的批号（９７０７０３）由药品监督管理
A human phase II human clinical observation was conducted using human purified Vero cell rabies vaccine (CIN-1 strain) manufactured by Shenyang Andy Biotechnology Co., Ltd. Observation program by the Chinese Academy of Preventive Medicine Institute of Epidemiology and Microbiology developed by the body after inoculation of serum antibody testing by the China Pharmaceutical and Biological Products Office is responsible for. Observe vaccine batch number (970703) by the drug supervision and management